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Summary 
The Yorkshire Health Study is a longitudinal observational regional health study collecting 
health information on the residents from the Yorkshire and Humberside region in England.  
The second wave of data collection is currently underway.  The study aims to inform National 
Health Service (NHS) and local authority health related decision making in Yorkshire, with 
wider implications from findings as well.  The first wave contains records for 27,806 
individuals (2010-2012), aged between 16 and 85 from one part of Yorkshire (South 
Yorkshire), with the second wave expanding data collection to the whole of the Yorkshire and 
2 
Humberside region.  Data were collected on current and long-standing health, health care 
usage and health-related behaviours, with a particular focus on weight and weight 
management.  The majority of individuals have also given consent for record linkage with 
routine clinical data, allowing the linking to disease diagnosis, medication use and health care 
usage.  The study encourages researchers to utilise the sample through the embedding of 
randomised controlled trials, other controlled trials and qualitative studies.  To access the 
anonymised data or use the sample to recruit participants to studies, researchers should 
contact Dr Clare Relton (c.relton@sheffield.ac.uk). 
MeSH keywords: Cohort Studies, Longitudinal Studies, Patient Selection, England, Obesity. 
 
Key Messages 
x The cohort research platform facilitates multiple randomised controlled trials to be run 
in the same population.  This allows greater comparability between studies. 
x The cohort offers greater focus for research surrounding obesity and weight 
management, particularly their association to long-term health conditions.  No other 
cohorts offer the detail required to inform policy decisions in this area. 
x Analysis of this data set has shown that the health-related quality of life measure EQ-
5D to be a useful tool for capturing differences in health and well-being after 
accounting for various long-standing health conditions. 
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Why was the cohort set up? 
The study began in 2009 as the South Yorkshire Cohort with the aims of collecting 
information on the health of the residents of South Yorkshire and providing a research 
platform for the region.  In 2014, the study was expanded and rebranded as the Yorkshire 
Health Study to collect information for the whole of the Yorkshire and Humberside region.  A 
wide range of variables were collected to provide information on demographic characteristics, 
current and long-standing health, well-being, health care usage and health-related behaviours.  
The original focus of the cohort was weight and weight management, particularly the 
relationships between obesity, health care and long-standing health conditions. This focus was 
based on the recommendations of the µ+HDOWKy Weight, Healthy Lives¶government report 
which had proposed five key aims for future research to tackle obesity levels in England (1): 
x A longitudinal approach to research (incorporating the short, medium and long term). 
x Exploring the association of obesity to other key health issues. 
x Analysing the impact of policies, with a focus on reducing social inequalities. 
x Evaluating the effectiveness of long term policies and interventions. 
x 7KHWDUJHWLQJRISRSXODWLRQJURXSVDQGLQFRUSRUDWLRQRIµQDWXUDOexperiments¶ 
The Yorkshire Health Study allows the investigation of each of these aims through a focused 
set of variables and a large sample size (2).  The depth of information provided allows a 
detailed investigation of variations in obesity to other dimensions of health, particularly 
chronic health conditions.  Other population cohort studies are less relevant to fulfilling these 
identified needs of the National Health Service (NHS) for obesity-related research (for 
example (3±5)). 
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The cohort is uniquely set up to facilitate WKHµFRKRUWPXOWLSOHUDQGRPLVHGFRQWUROled WULDO¶ 
approach to experimental research (6).  This approach utilises the large cohort study as a 
research platform to facilitate recruitment to multiple pragmatic randomised controlled trials 
(with treatment as usual as the control), as well as other health studies.  This approach 
provides a number of benefits to studies utilising the Yorkshire Health Study research 
platform: detailed information on potential research participants and their efficient (quick and 
inexpensive) identification and ongoing information as to the natural history of the condition 
and treatment as usual (2). The particular benefits for randomised controlled trials include 
long term outcomes as standard, increased comparability between each trial conducted within 
the cohort and increased efficiency particularly for expensive or high risk interventions (6).   
The study completed its first wave of data collection (2010 to 2012) and the second wave 
(2013 to 2015) to extend the data longitudinally is ongoing.  The study is expected to run for a 
minimum of ten years.  New variables will be added in future waves in response to the 
findings of research and the recommendations of health and social care commissioning 
bodies. 
Ethical approval for the cohort was obtained from the Leeds East NHS Research Ethics 
Committee on the 22th April 2010 (ref: 09/H1306/97). 
 
Who is in it? 
Sample region 
In the first wave, the sample region was South Yorkshire, an English metropolitan county in 
the Yorkshire and Humber region in England.  It consists of four large urban areas (the 
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metropolitan boroughs of Barnsley, Doncaster and Rotherham, along with the city of 
Sheffield) and surrounding rural areas, with a total population of 1,343,601 recorded at the 
2011 Census.  Data were also collected for a small number of residents of Derbyshire.  For 
subsequent waves, the sample region was expanded to the Yorkshire and Humberside 
µ*RYHUQPHQW2IILFH5HJLRQ¶ZLWKDWRWDOSRSXODWLRQRI&HQVXVPrevious 
research has shown that in much of South Yorkshire and Yorkshire as a whole, rates of 
obesity are higher than compared to the national average (7).  As such, the sample regions 
provide a useful setting for a cohort study that has a weight and weight management focus. 
 
Sampling strategy 
A two stage approach was used for the initial data collection (2).  Firstly, General Practitioner 
(GP) surgeries were contacted with a view to participating in the study (43 agreed; 50% 
acceptance).  Consenting GP surgeries then mailed letters of invitation for all patients aged 
between 16 and 85.  Included with the letter of invitation was an eight page questionnaire for 
data collection (see 2).  An online version of the questionnaire was also available.  Of the 
156,866 questionnaires sent out, 27,806 were returned (a response rate of 15.9%).  Of the 
27,806 participants who returned questionnaires, 22,179 (81.7%) gave consent to being 
contacted again and 22,150 (79.7%) gave consent for researchers to access their health 
records.  As from 2014, a µcitizen recruitment¶ strategy is being used to increase coverage and 
sample size.  Information about the study is promulgated through a regional media campaign, 
and all residents in the Yorkshire and Humber region are invited to participate via a 
questionnaire and online website (http://www.yorkshirehealthstudy.org/).  Data will also be 
collected from those who agreed to be contacted again in the first wave to extend the original 
dataset longitudinally. 
6 
 
Cohort characteristics 
Table 1 presents the baseline characteristics of participants in the first wave of the cohort by 
age, sex and deprivation quintile (using the Indices of Deprivation 2010 measure (8)) based 
on the residential postcode of the participant.  For comparison, the category proportions for 
the South Yorkshire population (based on the 2011 Census) are also included.   
(Table 1 here) 
Participants in the cohort are older than in the total South Yorkshire population and the 
proportion of females in the sample is also somewhat higher.  Participants from the lowest 
two quintiles of deprivation are over represented, and participants from the highest three areas 
are under-represented.  As such, there is slight bias in the data across these three variables in 
the cohort.  The majority of participants also reported being of White ethnicity (94.1%), 
which was over-representative of the ethic group (2011 Census; 90.5%).   
 
What has been measured? 
Table 2 summarises the variables collected.  The inclusion of 12 long-standing conditions 
(along with a free-text field for additional conditions) reflects the growing interest in the 
impact of multi-morbidity (9,10).  The EuroQoL EQ-5D health-related quality of life 
questionnaire (11) is included as part of the cohort questionnaire.  This measure is used within 
the NHS and is the National Institute for Health and Care Excellence¶V preferred measure of 
quality of life in economic evaluations (2,12).  In order to understand more about NHS and 
non NHS healthcare resource use, medication usage is also included. 
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(Table 2 here) 
The postcode of the individual allows each record to be geo-located.  From this, additional 
spatial information can be gathered (for example, see Table 1; the deprivation measure was 
collected from area data), allowing the analysis of phenomenon not included in the 
questionnaire (e.g. exposure to pollution).  GP surgery information can also be linked to 
participants, providing information relating to the characteristics of the primary healthcare 
provider used by each individual.  
Included in the questionnaire is an option for individuals to consent to allow researchers to 
access their health records.  Data linkage of individual records in the cohort to GP clinical 
records (e.g. morbidity, health care and medication usage) and other sources (e.g. Hospital 
Episode Statistics) is possible and discussions are currently ongoing. 
The second wave of data collection will collect the variables in the first wave (Table 2) 
excluding occupation, education or weight management.  It will additionally include data on 
levels of income, provision (and receipt) of informal and formal care of individuals, dietary 
intake, severity of long-term health conditions, and more detail on physical activity. 
 
What has it found? 
With the first wave of cohort data only recently collected, research is at an early stage.  The 
focus so far has been on understanding differences in weight management strategies and 
exploring the associated factors to health-related quality of life.  Some early results from these 
studies are presented here. 
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The cohort has been used to help inform the local councils¶ policy development, planning and 
resource allocation.  For example, DUHSRUWWRLQIRUPWKHµ-RLQW6WUDWHJLF1HHGV$VVHVVPHQW¶ 
of health and well-being for Sheffield City Council showed evidence of wide social 
inequalities in levels of obesity (13).  There were twice as many people classified as obese in 
the most deprived areas than compared to the least deprived (with the relative difference in 
the morbidly obese being even greater).  The cohort has also been used to provide estimates 
on the prevalence of long term health conditions and health-related behaviours. 
A second study explored the uptake of slimming clubs and weight loss medication 
(manuscript submitted).  There is little evidence surrounding how these weight management 
strategies varied by demographic factors, particularly deprivation.  The study found varying 
social gradients in the uptake of each strategy independent of age, gender and health (Figures 
1 and 2), with slimming clubs less likely to be used in deprived areas but weight loss 
medication more likely to be used (although the effect size for the latter was lower).  The 
results demonstrate the importance of targeting population groups with different strategies to 
effectively tackle obesity.   
(Figures 1 and 2 here) 
A number of studies have focused on the relationship between reported EQ-5D and long-
standing health conditions (11).  Firstly, a study examined whether the EQ-5D measure is too 
narrowly focused to reflect the impact of long-standing health conditions on subjective well-
being (manuscript submitted).  It was observed that long-standing health conditions did not 
have an independent and consistent impact on life satisfaction.  Therefore, it was concluded 
that the EQ-5D measure is a useful instrument to reflect the impact of health conditions on 
life satisfaction and no additional dimensions need to be added.  
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A second study focused on the impact of long-standing health conditions on reported EQ-5D 
(14).  Previous studies have shown an inconsistent relationship between chronic ill-health and 
quality of life measures, with the suggestion that this may be due to differences between the 
studies in the method used to measure quality of life.  The analysis showed that the long term 
conditions pain, depression, anxiety/nerves, and osteoarthritis had the largest negative effect 
on health-related quality of life (although all long term health conditions measured reported 
negative effects, independent of socio-demographic factors).  These results were consistent 
across each statistical methodology employed in the analysis. 
Researchers have also used the data to assess the relationship between BMI and EQ-5D, and 
whether the relationship is attenuated by long term health conditions (15).  A deviation from a 
healthy weighWLHWKHµQRUPDO¶%0,FDWHJRU\) was found to have a negative effect on health-
related quality of life (EQ-5D) independent of social, demographic and health factors.  
Removing each long term health condition from the analysis (compared to a single variable 
for long term condition) allowed an assessment to be made regarding the effect it had on the 
relationship association between BMI and EQ-5D for individuals with a BMI NJP2 
(Figure 3).  Diabetes, heart disease, osteoarthritis and high blood pressure were important 
mediating factors in the relationship and the results were consistent across each dimension of 
EQ-5D. 
(Figure 3 here) 
A number of research groups have used the platform to identify and invite potential 
participants to their studies.  Researchers investigated how people make decisions concerning 
weight management (16).  Decisions DERXWPDQDJLQJDQLQGLYLGXDO¶VZHLJKWwere found to be 
impacted by stigma surrounding obesity, as negative feelings affected clear thinking in the 
choices individuals made.  Drawing on their findings, a decision aid booklet was created to 
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help influence individuals to make good decisions about their weight control.  The results also 
led to the development of a questionnaire to assess the impact of obesity stigma (17).  
The first randomised controlled trial utilising the cohort multiple randomised controlled trial 
design is now being implemented (6). This trial is testing the effectiveness of treatment by 
homeopaths for people with self-reported depression (DEPSY) (http://www.controlled-
trials.com/ISRCTN02484593).   
A list of current projects can be viewed at http://www.yorkshirehealthstudy.org/#!your-
research-studies/c17r5. 
 
What are the main strengths and weaknesses? 
Strengths: 
x A large sample size covering a wide range of population sub-groups. 
x Longitudinal design for data collection. 
x Data collected on a broad range of health related variables. 
x A µresearch platform¶ designed to facilitate the running RIµcohort multiple 
randomised controlled trials¶ and facilitate participant identification and recruitment to 
health related research (6). 
x Consent to link the majority of individuals to their NHS health records. 
x Questions designed to be policy relevant, to encourage the collaboration between 
academia, local authorities and the NHS. 
Weaknesses: 
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x Some demographic bias with a higher proportion of elderly, female, White ethnicities 
and individuals from less deprived areas.  This was partly due to the low response rate. 
x The first wave was collected over three years, rather than at a single time point. 
 
Can I get hold of the data? Where can I find more? 
The data are managed by WKH8QLYHUVLW\RI6KHIILHOG¶V&OLQLFDO7ULDOV5HVHDUFK8QLW.  
Anonymised data and details regarding using the resource for recruiting participants to studies 
can be gathered by contacting Dr Clare Relton (c.relton@sheffield.ac.uk).  Multi-disciplinary 
collaboration is strongly encouraged. 
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Tables 
Table 1.  Distribution of demographic characteristics of the sample and the total population. 
Variable Cohort (%) Actual (%) 
Age 
  
16-25 6.9 14.8 
26-35 9.7 12.4 
36-45 13 22.3 
46-55 16.9 13.4 
56-65 22.2 11.4 
66-75 20.1 8.5 
76+ 9.9 7.0 
Missing 1.2 
 
   Sex 
  
Male 43.8 49.3 
Female 56.2 51.7 
   
Indices of Deprivation 2010 Quintile (8) 
  
Least deprived 14.5 9.3 
Low deprivation 25.2 15.5 
Average 16.6 18.1 
High deprivation 18.3 22.3 
Most deprived 25.1 34.8 
Missing 0.3 
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Table 2: Data collected in the first wave of the cohort. 
Dimension List of data available 
Personal 
Age, sex, ethnicity, number of children, height, weight, waist, body 
mass index, employment status, occupation, education, postcode. 
Health 
Long-standing conditions (tiredness/fatigue, pain, insomnia, 
anxiety/nerves, depression, diabetes, breathing problems, high blood 
pressure, heart disease, osteoarthritis, stroke, cancer), health-related 
quality of life (Euro-QoL-5D;(11)), medication (name, strength, type, 
prescription, what for). 
Health care 
Use of health services (hospital, General Practitioner, social/welfare, 
mental, alternative therapists). 
Health behaviour 
Smoking status, alcohol consumption, exercise (physical activity 
levels and type), concern over personal weight management, weight 
management strategy use (exercise, healthy eating, slimming clubs, 
weight loss medication, meal replacements). 
Well-being Life satisfaction. 
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Figures 
 
Figure 1: Adjusted odds ratios for neighbourhood deprivation quintile in analysing usage of 
slimming clubs (adjusted for age, sex and long-term health condition) (after manuscript 
submitted). 
 
Figure 2: Adjusted odds ratios for neighbourhood deprivation quintile in analysing usage of 
weight loss medication (adjusted for age, sex and long-term health condition) (after 
manuscript submitted). 
17 
 
Figure 3: Percentage of the association between body mass index and EQ-5D µexplained¶ by 
removing each long term health condition in comparison to a single variable for long term 
FRQGLWLRQIRULQGLYLGXDOVZLWK%0,NJP2 (after (15)). 
 
